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Summary
Differences in lipid metabolism associate with age-related
disease development and lifespan. Inflammation is a common
link between metabolic dysregulation and aging. Saturated
fatty acids (FAs) initiate pro-inflammatory signalling from many
cells including monocytes; however, no existing studies have
quantified age-associated changes in individual FAs in relation
to inflammatory phenotype. Therefore, we have determined
the plasma concentrations of distinct FAs by gas chromatogra-
phy in 26 healthy younger individuals (age < 30 years) and 21
healthy FA individuals (age > 50 years). Linear mixed models
were used to explore the association between circulating FAs,
age and cytokines. We showed that plasma saturated, poly-
and mono-unsaturated FAs increase with age. Circulating TNF-a
and IL-6 concentrations increased with age, whereas IL-10 and
TGF-b1 concentrations decreased. Oxidation of MitoSOX Red
was higher in leucocytes from FA adults, and plasma oxidized
glutathione concentrations were higher. There was significant
colinearity between plasma saturated FAs, indicative of their
metabolic relationships. Higher levels of the saturated FAs
C18:0 and C24:0 were associated with lower TGF-b1 concentra-
tions, and higher C16:0 were associated with higher TNF-a
concentrations. We further examined effects of the aging FA
profile on monocyte polarization and metabolism in THP1
monocytes. Monocytes preincubated with C16:0 increased
secretion of pro-inflammatory cytokines in response to phorbol
myristate acetate-induced differentiation through ceramide-de-
pendent inhibition of PPARc activity. Conversely, C18:1 primed
a pro-resolving macrophage which was PPARc dependent and
ceramide dependent and which required oxidative phosphory-
lation. These data suggest that a midlife adult FA profile
impairs the switch from proinflammatory to lower energy,
requiring anti-inflammatory macrophages through metabolic
reprogramming.
Key words: anti-inflammatory; macrophage; mitochondrial
ROS; oleate; oxidative phosphorylation; palmitate.
Introduction
During aging, there is a redistribution of body fat away from subcuta-
neous stores to other depots including muscle and viscera (Pararasa
et al., 2014). Visceral adipose tissue is less efficient in storing fatty acid
(FA) and there is a concomitant increase in circulating free fatty acids
(FFA) that promote insulin resistance leading to elevated blood glucose
concentrations and risk for type 2 diabetes (T2DM) (Carlsson et al.,
2000; Pilz et al., 2006). Raised fasting plasma FFA levels are associated
with an increase in risk factors for all-cause and cardiovascular mortality
such as blood pressure, impaired endothelial cell function and increased
inflammatory markers (Tripathy et al., 2003). However, not all FFA exert
the same effects. The anti-inflammatory effects of omega 3 FA have long
been reported and, more recently, saturated FAs have been linked
causally to inflammation and insulin resistance, acting on pancreatic
islets and monocytes in a Toll-like receptor (TLR) 4-dependent manner
(Huang et al., 2012). TLR4-activated monocytes migrate to the target
tissues, directed by a chemotactic gradient of chemokines and stromal
factors (Weber et al., 2004).
In tissues, monocytes differentiate into two major effector macro-
phage phenotypes, according to environmental cues, which are classi-
fied broadly into (‘M1’) classically activated, inflammatory and (‘M2’)
alternatively activated, pro-resolving phenotypes. Inflammatory mono-
cyte/macrophages phagocytose pathogens and cellular debris, and pro-
resolving monocyte/macrophages secrete wound healing and immuno-
suppressive factors (Gordon, 2003; Erwig & Henson, 2007; Mosser &
Edwards, 2008).
Classically activated M1 macrophages are polarized in response to
Th1 cytokines, for example IFNc or pathogen-associated molecular
patterns (PAMPs), for example LPS (Schwartz & Svistelnik, 2012), and are
involved primarily in defence against bacterial or viral pathogens. The M1
phenotype is characterized by elevated production of pro-inflammatory
cytokines TNF-a, IL-1b, IL-6, IL-8 and IL-12, accompanied by elevated
expression of pattern-recognition receptors, for example TLR and NOD-
like receptors (Martinez et al., 2009). In contrast, alternatively activated
M2 macrophages are polarized in response to Th2 cytokines IL-4/IL-13,
displaying a phenotype which limits inflammation through the produc-
tion of anti-inflammatory cytokines such as TGF-b1, increased surface
expression of scavenger receptors, extracellular matrix formation,
clearance of apoptotic cells and debris, and in the resolution of
inflammation (Devitt & Marshall, 2011; Lopez-Castejon et al., 2011;
Takeuch & Akira, 2011).
In metabolic disorders that are increasingly prevalent during aging,
there is an increase in the M1/M2 macrophage ratio (Zeyda et al., 2007;
Chinetti-Gbaguidi & Staels, 2011). This may be due to the accumulation
of visceral adipose tissue during aging; visceral adipose tissue-derived
cytokines recruit monocytes and promote their differentiation into M1
pro-inflammatory macrophages that are suggested to promote insulin
resistance (Lumeng & Saltiel, 2011). Similarly, prediabetic individuals
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have elevated circulating M1 monocyte phenotypes (Fadini et al., 2013).
In atherosclerotic plaques, macrophage phenotype associates with
plaque stability; M1 are localized in the rupture prone and M2 in the
cell-rich, stable regions, respectively (Stoger et al., 2012). Modulation of
monocyte/macrophage polarization offers a tangible opportunity to
reduce cardiovascular dysfunction in aging, T2DM and obesity (Ghattas
et al., 2013).
During monocyte differentiation, there is a metabolic switch towards
glycolysis in the early initiation of inflammation in M1 cells and oxidative
phosphorylation in M2 cells during the late adapting, resolving phases
(M2; Liu et al., 2012). The principal substrates for glycolysis and
oxidative phosphorylation are sugars and FA, respectively. This suggests
that an increase in circulating FA substrates may promote inflammatory
resolution. However, in T2DM mouse models, pancreatic b-cells respond
to a SFA diet by producing chemokines that recruit CD11b(+)Ly-6C(+)
M1-type proinflammatory monocytes/macrophages to islets (Eguchi
et al., 2012) suggesting that FA substrates have differing effects on
innate immunity. There are very little data examining the effects of
aging on FFA in healthy midlife adults, and to date, the FFA relationship
with the monocyte polarization process has not been investigated. It
is not known in aging whether the elevated FFA present can
affect atherosclerosis risk by influencing monocyte–macrophage
phenotype.
Recently, our group demonstrated that a pro-atherogenic monocyte
phenotype could be induced by palmitate (C16:0) via the de novo
synthesis of ceramides. In contrast, monounsaturated FA (MUFA)
prevented this phenotype (Gao et al., 2012). Therefore, we have
investigated the FA profile associated with healthy aging and examined
its relationship to monocyte phenotype, metabolism and polarization.
Results
FA profile in healthy aging
Anthropometric and biochemical characteristics of the young [24 (3.76)
years; mean standard deviation (SD)] and midlife [58 (6.1) years; mean
(SD)] male subjects recruited into this study are described in Table 1. We
limited our study to males to exclude the confounding effects of
hormonal changes in peri-/menopausal older women; for example the
decline in oestrogen concentration with age associates with monocyte
activation, an increase in very low density lipoprotein (VLDL) and
triglycerides and decrease of high density lipoprotein (HDL) in
menopausal women. All males were medication free and exhibited
normal blood glucose, cholesterol, triglycerides, systolic blood pressure
and waist-to-hip ratio. The body mass index (BMI), waist circumference,
diastolic blood pressure, plasma insulin and HOMA-IR were significantly
higher in midlife subjects (P < 0.05).
Concentrations of plasma total SFA, MUFA and PUFA in healthy
fasting mid-life male subjects were significantly greater than in younger,
healthy male adults (P < 0.05). Individual FA concentrations were noted
as significantly elevated in midlife adults for SFA C14:0 and C24:0
(P < 0.001), the MUFA C14:1, C18:1 and C24:1 (P < 0.05) and the
PUFA C18:3n6, C22:3n6 and C22:2 (P < 0.05; Table 2).
Aging oxidative and inflammatory phenotype
Samples were processed for oxidative stress biomarkers within 5 min of
blood collection. Mononuclear cell oxidation of MitoSOX Red was
elevated significantly, and plasma total glutathione concentrations were
decreased significantly in midlife subjects (P < 0.001; Fig. 1A,B).
Plasma pro-inflammatory cytokines (TNF-a and IL-6) were elevated
significantly in healthy midlife subjects (P < 0.01), whereas the concen-
tration of the anti-inflammatory cytokine IL-10 was lower (P < 0.05) and
TGF-b1 was not different between groups (Fig. 1C–F). These findings are
consistent with pro-oxidative and pro-inflammatory effects of aging.
FAs as predictors of age and plasma cytokines
Multiple-regression models were generated to predict age and plasma
cytokine concentrations. Very long-chain FA C24:0, C24:1 and C18:3n6
with diastolic blood pressure, cytokines and lipids predicted age
Table 2 Plasma fatty acid concentrations in healthy, fasting male subjects
Fatty acids
(lM)
Young (n = 26) Midlife (n = 21)
PMedian
Interquartile
range Median
Interquartile
range
C14:0 5.86 1.64–18.6 38.7 17.3–78.7 0.0014
C14:1 <LOD <LOD 12.9 0–52.4 <0.0001
C16:0 186 107.9–243 214 82.8–412 0.74
C16:1 6.99 1.78–15.9 19.8 0–45.5 0.3
C18:0 50.7 31.9–76.7 74.1 46.5–118 0.07
C18:1 130 63.3–327 235 133–470 0.035
C18:2 31.6 6.99–66.2 18.3 11.3–67.3 0.67
C18:3n6 35.6 23.5–73.6 56.6 48.7–120 0.049
C18:3n3 26.1 12.4–61.5 31.4 6.75–77.2 1
C22:2 <LOD < LOD <LOD <LOD–19 0.017
C24:0 7.67 2.87–17.5 33.2 12.55–83.4 0.0024
C24:1 12.3 6.26–43.0 52.7 21.7–112 0.0097
C22:6n3 <LOD < LOD–4.02 5.4 <LOD–17.3 0.034
Table 1 Baseline characteristics of healthy, fasting male subjects
Young, n = 26 Midlife, n = 21
Significance
Mean
Standard
deviation Mean
Standard
deviation P
Age (years) 24.16 3.76 57.53 6.07 <0.0001
Weight (Kg) 76.11 11.97 80.58 10.05 >0.05
Height (m) 1.785 0.71 1.808 0.08 >0.05
BMI Kg m2 22.71 2.88 24.53 2.22 0.038
Waist (cm) 88.92 6.82 98.54 7.07 0.0083
Hip (cm) 99.16 6.93 104.3 5.24 >0.05
Waist:hip ratio 0.8969 0.059 0.946 0.07 >0.05
Systolic blood
pressure
123.3 13.65 131.7 13.24 >0.05
Diastolic blood
pressure
73.86 10.09 87.06 9.75 0.0006
Heart rate 69.33 13.09 63.92 13.77 >0.05
Glucose (mM) 5.213 0.4 5.447 0.57 >0.05
Total cholesterol
(mM)
4.325 1.16 4.8 0.77 >0.05
HDL cholesterol
(mM)
1.01 0.22 0.9907 0.3 >0.05
LDL cholesterol
(mM)
2.85 1.04 3.453 1.04 >0.05
TG (md dL1) 62.68 0.29 35.95 0.15 >0.05
Insulin (U mL1) 8.588 1.56 12.47 7.18 0.0013
HOMA-IR 2.015 0.37 2.96 1.42 0.0032
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(P < 0.001; Table 3). The major FA predictor of plasma TNF-a was C16:0
(P < 0.001; Table S1, Supporting Information). Of the parameters tested,
plasma IL-6 concentration was predicted by FA only, including the PUFA,
C18:3n6 and C18:3n3 and the SFA C14:0 and C24:0 (P < 0.001;
Table S2). High plasma TGF-b1 concentration was predicted by low
plasma C24:0 and C18:0, low low-density lipoprotein (LDL) cholesterol,
age and high C18:3n6 (P = 0.014; Table S3). None of these analytes
predicted plasma IL-10 concentration.
FA prime monocytes for cytokine secretion according to
saturation not chain length
We have shown previously that the C16:0 and C18:1, the major SFA and
MUFA in plasma induce a pro- and anti-inflammatory phenotype,
respectively, as indicated by cell surface antigen expression in monocytes
(Gao et al., 2012). Here, we investigated whether the major FAs C16:0
and C18:1 or the FAs elevated ≥ fivefold with age (C14:0 and C24:1)
influenced redox state and monocyte cytokine production in vitro. FAs
are transported in vivo on albumin and for the purposes of our
experiments were delivered by bovine serum albumin (BSA); therefore,
BSA was used as vehicle control throughout. The presence of BSA had
no effect compared to untreated control (Fig. 2A). None of the cell
treatments had any significant effect on cell viability (data not shown).
While there was no difference in effect between SFA and MUFA on
cellular glutathione concentration, only C16:0 significantly increased
oxidation of MitoSOX Red over 24 h (P < 0.001; Fig. 2A,B). Addition of
MUFA increased triglyceride storage as shown by Oil Red O staining
(P < 0.05; Fig. 2C) in a manner that was inhibited by the diacylglycerol
transferase inhibitor etomoxir (Fig. 2D). However, in response to
increasing FA concentrations, cytokine secretion by THP1 monocytes
was not altered (Fig. S1, Supporting Information). Therefore, we
examined whether the presence of FAs may affect monocyte response
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E F Fig. 1 Oxidative stress and inflammation
increase with age. Blood was from healthy,
consenting male donors (years), (A) Total
plasma glutathione was determined by the
recycling assay and corrected for plasma
protein (mg) determined by the
bicinchoninic acid assay (Gao et al., 2012).
(B) Oxidation of MitoSOX Red in
mononuclear cells was by flow cytometry in
whole-blood samples after erythrocyte lysis
using Optilyse C. (C–F) Plasma cytokine
analysis (TNF-a, IL-6, TGF-b1 and IL-10) was
by ELISA. Data are presented as means and
standard deviation. Mann–Whitney U-tests
showed *P < 0.05, **P < 0.01 and
****P < 0.0001.
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to an activating stimulus of LPS. The following experiments were
conducted to investigate the effects of FA in the presence of a
submaximal LPS concentration.
Prior to activation with LPS (5 ng mL1) which induces submaximal
cytokine responses, THP1 monocytes were pretreated for 6 h with BSA,
SFA or MUFA. SFA C16:0 and C18:0 increased IL-6; C14:0, C16:0 and
C18:0 increased TNF-a secretion; and C18:0 inhibited IL-10 secretion
(P < 0.01). In contrast, C18:1 did not exert any priming effect on LPS-
induced TNF-a or IL-10 secretion, nor did it inhibit the secretion of IL-10
by monocytes after LPS activation (Fig. 2E–G). To investigate the
contribution of reactive oxygen species (ROS) and NFkB activation to
the SFA priming effect, monocytes were incubated with MnTBAP and
SN50, respectively. Scavenging ROS and inhibiting NFjB prevented the
priming effects of SFA (Fig. S2). Closer examination of the major plasma
MUFA C18:1 and SFA C16:0 confirmed that their effects on LPS-induced
TNF-a secretion were dose dependent (Fig. 2H,I) with C16:0 increasing
the sensitivity to LPS to near-maximal levels of cell activation. These
findings support the hypothesis that saturation is a major driver for the
inflammatory effects of FA.
Specific FAs recapitulate polarization effects of cytokines
during monocyte polarization to macrophages in a ceramide-
dependent manner
TNF-a and IL-6 secretion were up to tenfold higher from M1 than M2
THP-1 macrophages, but IL-10 secretion by M1 was only 15% of that
from M2 cells (Fig. 3A–C; P < 0.05). The M1-like phenotype was
mimicked by C16:0 priming. In contrast, C18:1 showed a trend to inhibit
TNF-a and IL-6 secretion compared to phorbol myristate acetate (PMA)
alone but did not affect PMA-induced IL-10 secretion. To better
understand the mechanism associated with C16:0-induced M1 polar-
ization, we determined whether lipid metabolism might be a contrib-
utory factor. In the presence of fumonisin B1 (FB1) to prevent ceramide
formation, rosiglitazone as a PPARc agonist and C18:1 as a competitor
for metabolic carrier molecules such as CoA, the C16:0-mediated
priming effect towards an M1 phenotype was abolished (Fig. 3D,E;
P < 0.001). Conversely, the inhibitory effect of C16:0 on IL-10 secretion
by PMA-differentiated cells was abolished by FB1, C18:1 and rosiglita-
zone (Fig. 3F).
Cellular metabolism mediates macrophage polarization
It has been reported previously that during monocyte differentiation,
there is a metabolic switch towards glycolysis in the early initiation of
inflammation in M1 cells and oxidative phosphorylation in M2 cells
during the late adapting, resolving phase in a SIRT1- and 6-dependent
manner (Liu et al., 2012). We examined whether FA saturation affected
metabolic switching. Consistent with previous reports, we observed that
M1 macrophages were unaffected by the MitoStress test, whereas M2
macrophages relied more on oxidative phosphorylation [oxygen con-
sumption rate (OCR); Fig. 4A]. After priming with C18:0, activation by
PMA induced THP-1 macrophages that were more glycolytic measured
as extracellular acidification (data not shown) than C18:1-primed THP-1
macrophages which had a metabolic profile consistent with M2
macrophages, that is dependent on oxidative phosphorylation. The
requirement for PPARc in metabolic switching was confirmed by the
increase in OCR for C16:0 primed macrophages in the presence of
rosiglitazone (R). In addition, co-incubation of C16:0 with an equal
concentration of C18:1 during priming resulted in greater OCR
dependence in macrophage basal OCR (Fig. 4B). Moreover, C16:0
caused a dose-dependent depletion of NAD+, and SIRT1 activity was
inhibited (Fig. 4C,D; P < 0.01). In contrast, monocyte activation after
priming by C18:1 led to an increase in SIRT1 deacetylase activity (Fig. 4D;
P < 0.001).
Using MitoTrackerTM Green FM to measure mitochondrial density
independently of membrane potential, we observed that M2 macro-
phages showed significantly greater MitoTrackerTM Green staining than
M1 macrophages (data not shown) and that in CD14+ leucocytes from
the peripheral blood of healthy adults, monocyte mitochondrial content
was lower in midlife adults compared to younger adults (Fig. 4E,F).
As previously identified in monocytes (Fig. 2), incubation with C18:1
but not C16:0 favoured triglyceride storage. The same dose-dependent
effect was observed in macrophages; M2 macrophages and C18:1-
primed macrophages preferentially stored triglycerides. Furthermore,
co-incubation with rosiglitazone, FB1 and C18:1 significantly increased
triglyceride storage in C16:0-treated cells (Fig. 4G,H). These studies
support the hypothesis that FAs differentially modulate lipid metabolism.
FA-dependent monocyte polarization is mediated by PPARc
Activity of the upstream lipid metabolism regulator, PPARc is modulated
by acetylation (Qiang et al., 2012). We isolated the nuclei of FA-primed
monocyte–macrophages and measured PPARc activation. C16:0 and
M1-differentiated macrophages showed lower PPARc consensus
sequence binding activity than the PMA-alone-differentiated macro-
phages (Fig. 5A; P < 0.001). In contrast, the M2 macrophage- binding
was significantly increased (P < 0.05). Nuclear proteins from M1
macrophages to PPARc consensus sequence was significantly decreased
compared to nuclear proteins from PMA-only-primed macrophages
(P < 0.05).
PPARc binding activity in C16:0-treated cells was increased from 15%
to more than 50% of PMA-control activity in the presence of FB1, C18:1
or rosiglitazone (P < 0.01; Fig. 5B). PPARc activation was responsible at
least in part for the metabolic switch, as PPARc siRNA transfected into
PMA-control and C18:1 primed monocyte–macrophages, and inhibited
the switch towards oxidative phosphorylation (Fig. 5F).
Acetylated PPARc is less active in binding CBP (CREB binding protein;
co-localises with PGC1alpha to facilitate PPAR transcription activity) and
so promotes NFjB interaction. Therefore, we reasoned that when SIRT1
activity was inhibited by C16:0, acetylation of PPARc would increase NF-
Table 3 Multiple linear regression model predicting age
Variable
Standardized
coefficient (b) P
Intercept 0.251
C24:0 0.829 <0.001
Diastolic blood pressure 0.508 0.003
C24:1 0.45 0.003
TNF-a 0.371 0.034
Triglyceride 0.344 0.011
TGF-b1 0.259 0.054
HDL cholesterol 0.294 0.023
C18:3n3 0.382 0.009
IL-6 0.575 0.01
Fatty acid that correlated significantly with age in a univariate regression model
were fitted into a multiple-regression model, adjusting for waist circumference and
cytokines. Model summary: R = 0.934, R2 = 0.873, adjusted R2 = 0.778,
P < 0.001. Bold values represent p values determined through multiple regression
analysis.
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jB-dependent cytokine production. Alternatively, NF-jB-dependent
cytokine production would be increased by PPARc siRNA. We investi-
gated this experimentally and knocked down PPARc with siRNA (Fig. S4).
TNF-a and IL-6 cytokine secretion by C16:0-primed macrophages was
suppressed by rosiglitazone, whereas rosiglitazone promoted IL-10
secretion (Fig. 5C–E). Furthermore, OCR indicative of oxidative phos-
phorylation was inhibited, whereas TNF-a secretion was significantly
enhanced from C18:1 primed and M2 macrophages when PPARc was
silenced (Fig. 5F,G). The inhibitory effect of C18:1 on IL-6 secretion was
not significantly affected when SIRT was inhibited; however, IL-10
secretion from M2 macrophages and C18:1-primed macrophages was
inhibited by sirtinol (Fig. 5H,I). These findings suggest that increased
PPARc acetylation in the presence of FAs contributes to the inflammatory
state.
Discussion
Healthy adults > 50 years of age have increased circulating plasma FFA,
and their plasma lipid profile is skewed towards longer FA chains. Here,
we have confirmed that inflammatory cytokines are elevated, and anti-
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Fig. 2 Fatty acids elicit oxidative stress and prime monocytes for cytokine secretion according to saturation not chain length. THP-1 monocytes were incubated for 24 h with
150 lM fatty acid (FA) conjugated to FA-free bovine serum albumin (BSA). (A) Cellular glutathione was determined by the recycling assay and corrected for protein
determined by bicinchoninic acid assay; (B) oxidation of MitoSOX Red was measured by flow cytometry. (C) The concentration- and FA-dependent accumulation of lipids in
monocytes over 24 h; and (D) the effect of etomoxir on lipid storage in monocytes after 50 lM FA was measured by Oil Red O staining and quantitated
spectrophotometrically at 490 nm. THP-1 monocytes pretreated with BSA  FA for 6 h prior to activation by 5 ng mL1 LPS for 18 h; effect on TNF-a (E), IL-6 (F) and IL-10
(G) was determined by ELISA. Concentration-dependent effect of C16:0 (H) and C18:1 (I) on TNF-a secretion after LPS activation (5 ng mL1). 0.2 lg mL1 LPS was used as
a positive control to induce maximal cytokine secretion. Data are presented as mean + SEM from three independent experiments. Data were analysed by ANOVA or paired
t-test analysis as appropriate compared to BSA control; *P < 0.05, **P < 0.01 and ***P < 0.001 and ## represents P < 0.01 compared with C16:0.
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inflammatory cytokine concentrations are lower in the midlife group. In a
multivariate regression model, SFAs, particularly long-chain SFA, predict
age and inflammation.
The waist circumference (an index of visceral adipose tissue storage),
BMI, diastolic blood pressure, plasma insulin and HOMA-IR are signif-
icantly higher in FA adults than younger controls. An increase in insulin
resistance is commonly observed in people aged over 50 years. This
leads to elevated circulating concentrations of insulin, glucose and FFA.
In our study, all volunteers were fasting and diet diary analysis suggested
that fat intake was not different in midlife adults (Fig. S3). Therefore, an
elevation of circulating FA is most likely to be a consequence of altered
cellular uptake, metabolism and biosynthesis. Others have confirmed
that methylation of the FA elongase 2 (ELOVL2) gene is altered during
aging (Garagnani et al., 2012). In independent studies, three of the four
most significantly altered CpG methylation sites were within the coding
region of ELOVL2 (Florath et al., 2014).
Of the FA that were analysed here, many were significantly increased
in midlife (i.e. C14:0, C14:1, C18:1, C18:3n6, C22:2; C22:6n3, C24:0
and C24:1), which are products of ELOVLs 3, 5 and 6 (Guillou et al.,
2010). Studies of ELOVL6 knockout mice have confirmed a crucial role
for ELOVL6 in the development of insulin resistance (Matsuzaka et al.,
2007), but its activity and relationship to plasma long-chain FA has not
been studied in human aging. One recent report has highlighted the
relationship between longevity and long-chain FA in other species;
longer-lived species had lower concentrations of circulating long-chain
FFA (Jove et al., 2013). Here, three of the five FAs that are downstream
of ELOVL6 were increased significantly in midlife although FA
concentrations did not correlate with HOMA-IR in healthy adults. An
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investigation of the relationship of these FA as predictors of insulin
resistance in obesity and prediabetes may provide insight into the
importance of ELOVL6 activity for insulin resistance in humans. In
addition to higher concentrations in MUFA and SFA from older adults,
the total PUFA was also significantly higher. The greatest difference was
observed for C18:3n6, whereas C18:3n3 concentrations were not
different between the two groups; these findings support previous
reports of a decline in delta 6 desaturase activity with age. We did not
detect free arachidonic acid; an important precursor of pro-inflammatory
prostaglandins. Others have measured arachidonic acid in plasma but
included those esterified in cholesterol and triglyceride rather than FFA
(Abdelmagid et al., 2015). Our subjects were fasting; others have shown
that arachidonic acid is retained in triglycerides, phospholipids and
cholesteryl esters during fasting (Cunnane, 1990).
We have shown previously that SFA but not MUFA uptake is
associated with an increase in monocyte mitochondrial superoxide anion
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radical concentration in the absence of any stimulus (Gao et al., 2012).
In the healthy mid-life adults, oxidation of MitoSOX Red was increased in
peripheral whole-blood mononuclear cells and glutathione was
depleted. SFAs may therefore contribute to redox regulated protein
activity via mitochondrial ROS. In contrast, MUFAs are less likely to cause
redox changes at the mitochondrion and are resistant to peroxidation.
The observed low level of FA unsaturation in tissues from long-lived
animals has been suggested to reduce risk of oxidative damage to lipid,
DNA and protein (Pamplona et al., 2004). This raises a paradox with our
data where the older adult population consistently exhibited higher
plasma concentrations of both MUFA and SFA. One potential explana-
tion of these findings is that the intracellular pathways which are
activated by MUFA may become less sensitive with age, in a similar
manner to the observed insulin resistance and decrease in sensitivity to
glucose that is observed in aging. Consequently, a skew towards a
higher ratio of MUFA:SFA may be required for anti-inflammatory
pathways to be activated in older adults.
Activation of the major inflammatory transcription factor NFjB is
redox dependent and likely predisposes to inflammaging (Martinez-
Hervas et al., 2010). We identified that SFA were able to prime the pro-
inflammatory monocyte response to LPS, and this effect was knocked
down by SN50 and was inhibitable by MnTBAP. This suggested that a
ROS-dependent target upstream of NFjB was important for regulating
transcription of inflammatory cytokines in older adults.
Previously, we have shown that C16:0 but not C18:1 increases
cytosolic ceramides in monocytes (Gao et al., 2012). C16:0 affects the
efficiency of the electron transport chain and disrupts the NAD+:NADH
ratio (Loskovich et al., 2005). Consistent with these previous reports,
here we observed that in monocytes, NAD+ was depleted by C16:0 but
not C18:1. The NAD+-dependent SIRT family have been implicated in
aging. In adipocytes, the regulation of PPARc activity by SIRT has been
shown to affect cellular lipid metabolism and because there is a close
relationship in gene expression profile between adipocytes and
monocytes, we reasoned that PPARc may be an important target in
monocytes (Charriere et al., 2003). Our studies have shown that PPARc
activity is differentially regulated by FAs with C18:1 acting as a PPARc
agonist. In contrast, C16:0 suppressed basal PPARc activity. Others
have shown that activation of PPARc by its traditional agonist
rosiglitazone reduces cell proliferation rate in U937 monocytes (Wang
et al., 2011b). Furthermore, rosiglitazone suppressed the expression
TLR4 and decreased the production of TNF-a following LPS treatment
(Wang et al., 2011a).
Consistent with these findings, the storage of triglycerides was
increased significantly in the presence of C18:1. C18:1 is preferentially
directed towards lipid storage and mitochondrial metabolism with
associated ROS production may be less likely because of increased
mitochondrial efficiency. Previous related work has shown in adipocytes
that PPARc senses incoming nonesterified long-chain FAs and induces
storage of long-chain FAs as triglycerides (Nakamura et al., 2014).
Others have reported that increasing diacylglycerol acyl transferase 1
(DGAT1) expression increases murine macrophage capacity for TG
storage, protects against FA-induced inflammatory activation and is
sufficient to reduce the inflammatory and metabolic consequences of
diet-induced obesity (Koliwad et al., 2010). However, the effects of
PPARc activation on DGAT1 expression vary according to tissues with
both increases and decreases in expression being reported in other cells
(Shi et al., 2013).
Studies by Liu et al. (2012) showed that during monocyte
differentiation, there is a metabolic switch towards glycolysis in the
early initiation of inflammation in M1 cells and oxidative phosphory-
lation in M2 cells during the late adapting, resolving phases. More
recently, a peptide mimicking ApoA1 that promotes cholesterol efflux
from monocyte-derived macrophages was shown to promote expres-
sion of genes required for oxidative phosphorylation with a concomi-
tant increase in mitochondrial oxygen consumption (Datta et al.,
2015). Our data show that polarization is differentially affected by the
nature of FA. The SFA C16:0 polarized monocytes towards M1
macrophages, conversely, C18:1-polarized monocytes to M2 macro-
phages that showed increased dependency on oxidative phosphory-
lation. Polarization towards M1 phenotype was associated with PPARc
inhibition, whereas polarization towards M2 associated with PPARc
activation. Incubating C16:0-treated cells with rosiglitazone (PPARc
agonist) maintained PPARc activity and decreased proinflammatory
cytokine secretion. Conversely, knockdown of PPARc in the C18:1-
treated monocytes elicited a more M1-like polarization path with cells
showing increased IL-6 production and increasing dependency on
glycolysis.
Together, these data suggest a mechanism whereby PPARc is a
controlling node for macrophage polarization and is sensitive to
nutrients. A similar hypothesis is proposed in muscle, where control of
acetylation serves as a critical node to control mitochondrial biogenesis,
insulin sensitivity, glucose transport, ROS (Menzies & Auwerx, 2013).
When NAD+ is depleted through increasing metabolism and uncoupling
of the mitochondrial chain, the loss of SIRT activity will increase
regulatory protein acetylation. Others have shown that PPAR acetylation
affects its interaction with cofactors and other regulatory factors. For
example, when deacetylated, its can no longer bind its inhibitor Dbc1 so
promotes expression of brown adipose tissue genes, mitochondrial
biogenesis genes and DGAT that favour lipid storage and oxidative
phosphorylation (Qiang et al., 2012). When downregulated, its interac-
tion with CBP is affected that in turn decreases NFkB activity and the
secretion of TNF-a is suppressed (Konstantinopoulos et al., 2007).
However, when acetylated, for example when SFA are high and NAD+ is
low, PPARc activity is low, CBP interaction high and hence NFkB-directed
transcription is increased. NF-kB/PPARc expressional ‘on/off’ switches are
common molecular events during colorectal carcinogenesis (Kon-
stantinopoulos et al., 2007) and their wider importance in aging merits
further investigation.
We have identified a FA profile that predicts inflammatory phenotype.
Moreover, de novo ceramide synthesis and suppression of PPARc drives
monocytes towards an inflammatory macrophage phenotype in the
presence of C16:0. This inflammatory phenotype predominantly relies on
glycolysis for energy, an effect that can be mitigated by rosiglitazone and
oleate (C18:1).
We suggest that in monocytes, the epigenetic control of PPARc by
altered nutrient profile controls the inflammatory phenotype. Our studies
have identified a novel control node for inflammaging. This offers an
explanatory mechanism of how diets rich in MUFA that lead to increased
circulating MUFA such as the Mediterranean diet may be anti-inflam-
matory via PPARc activation. In addition, it offers the opportunity for
developing selective modulators such as agonists that offer improved
specificity to promote PPARc activity and inhibit NFjB to support healthy
aging (Xie et al., 2015).
Experimental procedures
Volunteers
Young male adults (18–35 years old; n = 26) and older male adults
(50–70 years old, n = 21) were recruited for this study by local advertise-
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ment. Volunteers were healthy, nonsmokers and were not taking any
disease modifying or anti-inflammatory medication or nutritional supple-
ments. Exclusion criteria were triglyceride < 2 mM and total cholesterol
> 5.7 mM. Participants provided informed written consent, and ethical
approval was obtained from the Aston University Ethics Committee.
Blood measurements and processing
After an overnight fast, whole blood was drawn into EDTA between
8:00 and 10:30 hours. Anthropometric measurements were recorded.
Biochemical indices (glucose, total cholesterol, HDL cholesterol and
triglycerides) were measured using a Reflotron blood analyser (Boehrin-
ger Mannheim GmbH, Mannheim, Germany). Plasma insulin was
determined by ELISA (Mercodia, Uppsala, Sweden). LDL cholesterol
was calculated using the Friedewald equation. Plasma was prepared by
centrifugation at 250 g for 10 min.
FA analysis by gas chromatography
Analysis of the nonesterified FA profile profile of fasted plasma
samples was adapted from Ichihara & Fukubayashi (2010) Briefly, after
addition of internal standard C17 FA, lipids were extracted from
500 lL of plasma using chloroform methanol (2:1, 0.05% BHT) and
subsequently centrifuged at 700 g for 10 min. The chloroform layer
was dried under nitrogen and FA were methylated using 200 lL
toluene, 1.5 mL methanol and 0.3 mL HCl in methanol at 100 °C for
~20 min in PTFE-sealed glass vials. The FA methyl esters (FAMEs) were
subsequently extracted with 1 mL of hexane and 1 mL of water,
evaporated under nitrogen and resuspended in 50 lL of hexane prior
to separation by GC using a HP-Innowax polyethylene glycol polar
column, with flame-ionization detection. Identification of FA peaks
was determined against peak areas of a Supelco 37 FAME mix
standard.
Conjugation of FA to BSA
Stock solutions of FA (200 mM) were prepared by dissolving their sodium
salts into 0.1 M NaOH in 70% ethanol at 60 °C and conjugated to BSA
as previously described (Gao et al., 2012).
Cell culture
THP-1 monocytes were maintained in RPMI 1640 with 10% foetal
bovine serum at 37 °C in humidified 5% CO2/95% air incubator. To
investigate the effect of FA on priming, THP-1 monocytes (106 mL1)
were pretreated with either FA (300 lM) or BSA control for 6 h prior to
submaximal activation by LPS (5 ng mL1) for a further 18 h. As
previously described, cell viability was unaffected at these concentrations
(Gao et al., 2012). As a positive control, maximal activation of THP-1
cells was achieved using 200 ng mL1 LPS. To investigate the effect of
FA on polarity during differentiation into macrophages, THP-1 mono-
cytes (106 mL1) were pretreated with either FA (300 lM) or BSA control
for 6 h prior to differentiation with PMA (320 nM) for a further 18 h. For
inhibition experiments, THP-1 monocytes were incubated with FB1
(50 lM), C18:1 (300 lM), 25 lM sirtinol and rosiglitazone (25 lM) in the
presence or absence of C18:0 (300 lM). As a positive control for
monocyte differentiation into M1 or M2 macrophages, THP1 monocytes
were co-incubated with cytokine cocktails for 24 h (100 ng mL1 LPS
and 20 ng mL1 IFNc for M1 or 20 ng mL1 IL-4 and 20 ng mL1 IL-13
for M2).
Mitochondrial superoxide generation
Mitochondrial superoxide was determined in mononuclear cells imme-
diately after blood collection. Whole blood that had been incubated with
MitoSOX Red (1.25 lM; Invitrogen, Loughborough, UK) for 30 min
exactly was immediately treated with Optilyse C prior to analysis by flow
cytometry. For in vitro experiments, mitochondrial superoxide produc-
tion was determined in differentiated THP-1 macrophages after 24 h
treatment using MitoSOX Red (1.25 lM; Invitrogen) after staining for
30 min.
Glutathione determination
Total glutathione was measured using the dithionitrobisbenzoic acid
recycling assay as described previously (Gao et al., 2012).
Analysis of IL-6, IL-10, TNF-a and TGF-b1 cytokine levels
Circulating cytokines were determined by ELISA using undiluted
plasma. To determine secreted cytokines during in vitro experiments,
cells were treated with FA or control for 6 h and differentiated by PMA
for 18 h. Cells were gently removed by pipetting and scraping. Cells
were pelleted (100 g, 5 min) and cell-free media containing cytokines
were stored at 20 °C prior to analysis for IL-6, IL-10, TNF-a
(Peprotech, London, UK) and TGF-b1 (R&D Systems, Abingdon, UK)
by ELISA.
Oil Red O staining for neutral lipids
Post-FA or control treatments, 2 9 106 THP1 cells were removed from
multi-well plates by gentle pipetting and scraping and were washed in
phosphate-buffered saline, then fixed with 4% w/v paraformaldehyde,
and stained for 15 min with Oil Red O. Cells were then washed once in
PBS, before extraction of stained lipids with isopropanol. Samples were
centrifuged at 100 g for 2 min, with supernatants then transferred to a
96-well plate and absorbance measured at 490 nm.
Assessment of PPARc activity
The activity of PPARc in the nuclear fraction of THP1 cells was assessed
using a TransAM PPARc Transcription Factor Assay Kit (Active Motif, La
Hulpe, Belgium) ELISA.
Analysis of metabolic phenotype
Differentiated macrophages in 24-well plates were centrifuged gently
(40 g, 30 s) before removal of supplemented RPMI 1640. Medium was
replaced by bicarbonate-free PBS supplemented with 5 mM glucose,
2 mM L-glutamine and 1 mM sodium pyruvate 1 h prior to analysis.
Extracellular acidification rates and OCRs were measured under basal
conditions and the MitoStress test using XF-24 Extracellular Flux Analyzer
(Seahorse Bioscience, Copenhagen, Denmark).
SIRT1 activity analysis
THP-1 cells were washed with ice-cold PBS, lysed and the nuclear
fraction collected by centrifugation according to the manufacturer’s
instructions. SIRT1 activity was measured in nuclear extract (15 lg
of protein) using a kit purchased from Sigma-Aldrich (Dorset,
England, UK).
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Assessment NAD+:NADH ratio
The NAD+:NADH ratio in THP-1 cells was assessed using a kit purchased
from Abcam (Cambridge, UK).
PPARc RNA interference
Transient transfection with PPARc-siRNA was performed using lipofec-
tamine RNA-imax reagent according to a modified protocol and manu-
facturer’s instructions. THP1 cells at approximately 50–70% confluence
were transfected with siPPARc or scrambled PPARc-siRNA (scr/siRNA)
(Invitrogen). Cell culture medium was replaced at 6 h after transfection,
and cells were then further incubated for 16–24 h before exposure to FA.
SDS-PAGE and western blotting
To confirm knockdown of PPARc by siRNA, cells were lysed into RIPA
buffer and 20 lg of each lysate in Laemmli buffer was separated by
10% SDS-PAGE, transferred onto a PVDF membrane and blocked with
3% BSA. The membrane was probed with primary polyclonal anti-PPARc
(1:1000; Santa Cruz, Dallas, USA) or monoclonal anti-b-actin (1:5000)
for 2 h at room temperature followed by extensive washing then
incubation with horseradish peroxidase-labelled mouse anti-rabbit IgG
(1:15 000) or goat anti-mouse IgG (1:20 000) for 2 h. The immunore-
active bands were detected by enhanced chemiluminescence reagent
(GE HealthCare, Amersham, UK).
Statistical analysis
Data analysed using SPSS version 21 (Armonk, New York, USA).
Descriptive analysis of biochemical data from volunteers was performed
for all variables with percentages, mean (standard deviation) and median
(interquartile range), as appropriate. Baseline comparison between
young and midlife group performed using appropriate statistical tests:
chi-squared tests for categorical variables, Student’s t-test for normally
distributed continuous variables and Mann–Whitney U-test for non-
normally distributed continuous variables. Univariate analysis was
performed to determine the FA variables which were correlated
significantly with age and markers of inflammation. These variables
were then fitted into a multiple linear regression model by a backward
stepwise method. Variables with a variance inflation factor > 10 and F
statistic > 0.10 were removed from the next step of the model. Missing
values were analysed pairwise.
For in vitro studies, statistical significance was determined by ANOVA
with Tukey’s post-test using GRAPHPAD PRISM version 6 (La Jolla, California,
USA).
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